M & A Law Prof Blog

Editor: Brian JM Quinn
Boston College Law School

Monday, October 22, 2007

Bioenvision Deal Approved

Bioenvision, Inc. announced yesterday that its stockholders had voted to approve the acquisition of the company by Genzyme at a reconvened meeting of its shareholders. Fifty-six percent of Bioenvision's shares of common stock and preferred stock supported the merger. This represented approximately 67 percent of the total shares voted. 

For my prior posts on this deal see:

Bioenvision and DGCL 231(c)

Bioenvision: Wins in Delaware?!

Bioenvision: Pulling a Topps or an OSI?


Takeovers | Permalink

TrackBack URL for this entry:


Listed below are links to weblogs that reference Bioenvision Deal Approved:


Post a comment